Company launches automated hematology analyzers in US

Sysmex XN-L Automated
Hematology Analyzers
Sysmex America, Inc. has launched its XN-L™ automated hematology analyzers in the US. The company says this new, smaller XN-L line delivers the same clinical and operational value as its XN-Series™ to lower-volume hematology laboratories. “The XN-Series has been our flagship hematology analyzer line, and, today, we... [Read Article]

Countries with high malaria burden don’t receive research funding

Researchers in the lab
Photo by Rhoda Baer
A new study has revealed inequalities in malaria research funding in sub-Saharan Africa. The study showed that some countries with a high malaria burden—such as Sierra Leone, Congo, Central African Republic, and Guinea—received little to no funding for malaria research in recent years. However, other... [Read Article]

Single-dose NEPA found non-inferior to aprepitant/granisetron

Nurse hanging bags
of chemotherapy drugs
Photo by Bill Branson
In a head-to-head study comparing a single-dose oral antiemetic to a 3-day oral regimen, the single dose has shown itself to be non-inferior to the multi-day regimen in preventing chemotherapy-induced nausea and vomiting (CINV). The investigators evaluated netupitant/palonosetron (NEPA) against aprepitant/granisetron (APR/GRAN) in patients on... [Read Article]

Developments on the malaria front

Malaria-infected cell bursting
Image by Peter H. Seeberger
Progress is being made in the battle against malaria. From engineering a mosquito-killing fungus to discovering new anti-malaria targets, scientists are making advances on multiple malaria fronts. And US aid to combat malaria is having a positive impact on reducing childhood mortality in 19 sub-Saharan countries.  A... [Read Article]

Malaria infection can lead to chronic bone loss

Plasmodium parasite
infecting a red blood cell
Image from St. Jude
Children’s Research Hospital
Malaria infection caused by Plasmodium falciparum, even after a one-time illness, can cause long-term bone loss, researchers report. Parasite byproducts remain in the bone marrow and induce MyD88-dependent inflammatory responses in osteoclast and osteoblast precursors, resulting in bone resorption. Researchers... [Read Article]